rxstat › Shortages › Glyburide

Glyburide shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Glyburide is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 of 10
Reports on file
20

Reports by product

Anticipated
GLYBURIDE
5MG · TABLET · SANIS HEALTH INC
DIN 02350467 · Disruption of the manufacture of the drug.
Discontinued
TEVA-GLYBURIDE
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 01913670
Resolved
TEVA-GLYBURIDE
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 01913670 · ended Feb 28, 2024 · Disruption of the manufacture of the drug.
Discontinued
GLYBURIDE
2.5MG · TABLET · PRO DOC LIMITEE
DIN 01959352
Discontinued
GLYBURIDE
5MG · TABLET · PRO DOC LIMITEE
DIN 02485664
Discontinued
PMS-GLYBURIDE
5MG · TABLET · PHARMASCIENCE INC
DIN 02236734
Resolved
APO GLYBURIDE TAB 2.5MG
2.5MG · TABLET · APOTEX INC
DIN 01913654 · ended Oct 2, 2020 · Disruption of the manufacture of the drug.
Discontinued
DIABETA
5MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02224569
Discontinued
DIABETA
2.5MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02224550
Resolved
PMS-GLYBURIDE
5MG · TABLET · PHARMASCIENCE INC
DIN 02236734 · ended Jun 9, 2020 · Other (Please describe in comments)
Resolved
PMS-GLYBURIDE
5MG · TABLET · PHARMASCIENCE INC
DIN 02236734 · ended Jun 9, 2020 · Other (Please describe in comments)
Resolved
APO GLYBURIDE TAB 2.5MG
2.5MG · TABLET · APOTEX INC
DIN 01913654 · ended Dec 3, 2019 · Disruption of the manufacture of the drug.

Showing 12 of 20 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Glyburide to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Glyburide is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BB).

Recent changes

Common questions

When will Glyburide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Glyburide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (blood glucose lowering drugs, excl. insulins)

Widespread shortageCanagliflozin2 of 4 reported products affected · est. return Dec 4, 2026Widespread shortageSitagliptin12 of 24 reported products affected · est. return Jan 7, 2027Widespread shortageTirzepatide6 of 6 reported products affectedPartial shortageDapagliflozin4 of 11 reported products affected · est. return Jul 24, 2026Partial shortageDapagliflozin Metformin2 of 6 reported products affected · est. return Jul 24, 2026Partial shortageGliclazide2 of 20 reported products affected

All blood glucose lowering drugs, excl. insulins shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.